7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.

          Related collections

          Author and article information

          Journal
          Arch. Bronconeumol.
          Archivos de bronconeumologia
          Elsevier BV
          1579-2129
          0300-2896
          Mar 2017
          : 53
          : 3
          Affiliations
          [1 ] Universidad de Marburg, Marburg, Alemania, Miembro del Centro Alemán para Investigación Pulmonar (DZL). Electronic address: claus.vogelmeier@med.uni-marburg.de.
          [2 ] Lewis Katz School of Medicine at Temple University, Filadelfia, Pensilvania, EE. UU.
          [3 ] New York-Presbyterian Hospital, Weil Cornell Medical Center, Nueva York, Nueva York, EE. UU.
          [4 ] University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, Texas, EE. UU.
          [5 ] National Heart and Lung Institute, Imperial College, Londres, Reino Unido.
          [6 ] McGill University Health Centre, McGill University, Montreal, Canadá.
          [7 ] Brigham and Women's Hospital Boston, Massachusetts, EE. UU.
          [8 ] Laboratorio Central Estatal para Enfermedades Respiratorias, Instituto de Enfermedades Respiratorias de Guangzhou, Primer Hospital Afiliado de la Universidad de Medicina de Guangzhou, Guangzhou, República Popular de China.
          [9 ] Universidad de Lovaina, Lovaina, Bélgica.
          [10 ] Universidad de Módena y Reggio Emilia, Módena, Italia.
          [11 ] Flinders University Faculty of Medicine, Bedford Park, South Australia Australia.
          [12 ] Royal Devon & Exeter Hospital, Exeter, Reino Unido.
          [13 ] Universidad de la República Montevideo, Uruguay.
          [14 ] Facultad de Medicina de la Universidad de Hokkaido, Japón.
          [15 ] Hôpital Cochin (APHP), Universidad Paris Descartes, París, Francia.
          [16 ] Instituto del Tórax, Hospital Clínic, Universitat de Barcelona, Barcelona, España.
          [17 ] St. Paul's Hospital, University of British Columbia, Vancouver, Canadá.
          [18 ] University of Manchester, Manchester, Reino Unido.
          [19 ] University Hospital, Birmingham, Reino Unido.
          [20 ] Imperial College London, Londres, Reino Unido.
          [21 ] Hospital Clínic, Universitat de Barcelona, Ciberes, Barcelona, España.
          Article
          S0300-2896(17)30035-2
          10.1016/j.arbres.2017.02.001
          28274597

          Comments

          Comment on this article